🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with alt normalization rates on glp-1? Page 5

Has anyone dealt with alt normalization rates on glp-1?

laura_annarbor Fri, Jan 9, 2026 at 9:24 PM 23 replies 1,414 viewsPage 5 of 5
MaxMetOK
Member
312
1,123
Dec 2024
Oklahoma
Jan 17, 2026 at 6:18 PM#21

Following on from Dr.RaviCardio — and this may be the naive question:

Was that from a primary source or from a summary of one?

39 12PharmHunterJen, TomTeleRx, DoseLogDan and 36 others
Reply Quote Save Share Report
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Jan 19, 2026 at 2:56 PM#22
steph_laguna said:
It helps to say which part of this you are uncertain about.

I read this differently from steph_laguna, on substance rather than tone. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

40 13FitDadDave, RunnerRach, TrialNerd_Beth and 37 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Jan 21, 2026 at 11:33 AM#23
steph_laguna said:
It helps to say which part of this you are uncertain about.

No disagreement with steph_laguna. One condition attached. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

41 14hans_munich, jason_sac26, chris_chi24 and 38 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jan 23, 2026 at 8:09 AM#24
steph_laguna said:
It helps to say which part of this you are uncertain about.

That reframing is the part I needed. Taking it to my next appointment.

Last edited: Jan 23, 2026 at 12:09 PM
42 15SandraNC_45, Dr.EndoIndy, tom_AK and 39 others
Reply Quote Save Share Report
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Jan 25, 2026 at 4:44 AM#25

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

43 16KristenIndy, MarkLI_maint, Dr.PeteFamMed and 40 others
Reply Quote Save Share Report
1345

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register